Autopsy report · NCT02161705

Pre-op Paravertebral Blocks to Decrease Post-op Pain Following Mastectomy With Immediate Tissue Expander (TE) Reconstruction

“Poor accrual due to change in standard of care procedure.”

The sponsor’s own words in the registry.

Life of this trial

• Registered 1 month before it started.
• Ran for about 4 years 7 months before it stopped.
• 18 participants enrolled.
• Results were posted on the registry 1 year after it ended.

Vital statistics

Status

Terminated

Phase

Phase 3

Sponsor

Johns Hopkins University

Sponsor type

University, hospital or other

Conditions

Postoperative Pain; Postoperative Nausea and Vomiting; Quality of Life

Interventions

Ropivacaine; Saline

Participants

18

Sites

1

Countries

United States

Trials that died the same way

• Pembrolizumab and Olaparib in Cervical Cancer Patients
  “Poor accrual related to change in standard of care treatment for this population.” (88% match in meaning)
• Fluciclovine (Axumin) PET/CT vs. NaF PET/CT in Prostate Cancer Osseous Metastatic Disease
  “Poor patient accrual” (76% match in meaning)
• SOX as Salvage Treatment in Nasopharyngeal Carcinoma
  “poor accrual of eligible patients” (72% match in meaning)
• Image Guided Intensity Modulated Reirradiation (IG-IMRT) With Cetuximab for Locoregionally Confined Recurrent Head and Neck Squamous Cell Carcinoma
  “Inadequate patient accrual” (71% match in meaning)
• Abiraterone-Rechallenge Study for CRPC Patients
  “Lack of Patient accrual” (67% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.